← All stocks

Hanover Bancorp, Inc. /MD

HNVR No buying or selling

CIK 0001828588 #3965 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

PUORRO MICHAEL P

Chairman & CEO

—

321,663

4.56%

$8.65M

+7.1%

Negrin Metin

Director

—

238,647

3.38%

$6.41M

+1.2%

Golden Robert

Director

—

210,856

2.99%

$5.67M

−21.0%

Katz Michael David M.D.

Director

—

152,202

2.16%

$4.09M

−1.3%

Sisti Elena

Director

—

105,016

1.49%

$2.82M

+3.1%

Wilcox McClelland W

President

—

97,697

1.38%

$2.63M

+19.8%

Sorrenti John R

Director

—

47,209

0.6691%

$1.27M

+6.6%

Abraham Varkey

Director

—

45,670

0.6473%

$1.23M

+6.8%

Okun Philip A

Director

—

42,669

0.6048%

$1.15M

+7.4%

Haspel Ahron H

Director

—

29,035

0.4115%

$780.46K

+11.2%

Corbett Kevin

EVP & Chief Credit Officer

—

27,936

0.3960%

$750.92K

+18.2%

Burke Lance P

SEVP & Chief Financial Officer

—

27,931

0.3959%

$750.79K

+30.5%

O'Connor Kevin M

President

—

22,300

0.3161%

$599.42K

+869.6%

Diiorio Lisa A

FSVP & Chief Accounting Off.

—

17,899

0.2537%

$481.13K

+20.2%

Burns Joseph F

EVP & Chief Lending Officer

—

11,505

0.1631%

$309.25K

+43.8%

Vivona John P

EVP & Chief Risk Officer

—

5,152

0.0730%

$138.49K

+61.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 10,000

History held since 11 May 2022